Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Feb;46(2):97–103. doi: 10.1136/jcp.46.2.97

The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.

B T Colvin 1, T W Barrowcliffe 1
PMCID: PMC501136  PMID: 8459048

Full text

PDF
97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrowcliffe T. W., Curtis A. D., Johnson E. A., Thomas D. P. An international standard for low molecular weight heparin. Thromb Haemost. 1988 Aug 30;60(1):1–7. [PubMed] [Google Scholar]
  2. Bentley P. G., Kakkar V. V., Scully M. F., MacGregor I. R., Webb P., Chan P., Jones N. An objective study of alternative methods of heparin administration. Thromb Res. 1980 Apr 1;18(1-2):177–187. doi: 10.1016/0049-3848(80)90182-6. [DOI] [PubMed] [Google Scholar]
  3. Boneu B., Caranobe C., Sie P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Haematol. 1990 Jul;3(3):531–544. doi: 10.1016/s0950-3536(05)80017-4. [DOI] [PubMed] [Google Scholar]
  4. Collins R., Scrimgeour A., Yusuf S., Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988 May 5;318(18):1162–1173. doi: 10.1056/NEJM198805053181805. [DOI] [PubMed] [Google Scholar]
  5. Dahlman T., Lindvall N., Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum. Br J Obstet Gynaecol. 1990 Mar;97(3):221–228. doi: 10.1111/j.1471-0528.1990.tb01785.x. [DOI] [PubMed] [Google Scholar]
  6. Gallus A., Jackaman J., Tillett J., Mills W., Wycherley A. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet. 1986 Dec 6;2(8519):1293–1296. doi: 10.1016/s0140-6736(86)91431-5. [DOI] [PubMed] [Google Scholar]
  7. Harenberg J., Würzner B., Zimmermann R., Schettler G. Bioavailability and antagonization of the low molecular weight heparin CY 216 in man. Thromb Res. 1986 Nov 15;44(4):549–554. doi: 10.1016/0049-3848(86)90333-6. [DOI] [PubMed] [Google Scholar]
  8. Hellgren M., Tengborn L., Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest. 1982;14(2):127–141. doi: 10.1159/000299460. [DOI] [PubMed] [Google Scholar]
  9. Hirsh J., Levine M. N. Low molecular weight heparin. Blood. 1992 Jan 1;79(1):1–17. [PubMed] [Google Scholar]
  10. Hsia J., Hamilton W. P., Kleiman N., Roberts R., Chaitman B. R., Ross A. M. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. N Engl J Med. 1990 Nov 22;323(21):1433–1437. doi: 10.1056/NEJM199011223232101. [DOI] [PubMed] [Google Scholar]
  11. Hull R. D., Raskob G. E., Pineo G. F., Green D., Trowbridge A. A., Elliott C. G., Lerner R. G., Hall J., Sparling T., Brettell H. R. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med. 1992 Apr 9;326(15):975–982. doi: 10.1056/NEJM199204093261502. [DOI] [PubMed] [Google Scholar]
  12. Hull R. D., Raskob G. E., Rosenbloom D., Panju A. A., Brill-Edwards P., Ginsberg J. S., Hirsh J., Martin G. J., Green D. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 1990 May 3;322(18):1260–1264. doi: 10.1056/NEJM199005033221802. [DOI] [PubMed] [Google Scholar]
  13. Ireland H., Lane D. A., Curtis J. R. Objective assessment of heparin requirements for hemodialysis in humans. J Lab Clin Med. 1984 Apr;103(4):643–652. [PubMed] [Google Scholar]
  14. Iturbe-Alessio I., Fonseca M. C., Mutchinik O., Santos M. A., Zajarías A., Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med. 1986 Nov 27;315(22):1390–1393. doi: 10.1056/NEJM198611273152205. [DOI] [PubMed] [Google Scholar]
  15. Kakkar V. V., Stamatakis J. D., Bentley P. G., Lawrence D., de Haas H. A., Ward V. P. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine. JAMA. 1979 Jan 5;241(1):39–42. [PubMed] [Google Scholar]
  16. Kamath B. S., Fozard J. R. Control of heparinisation during cardiopulmonary bypass. Experience with the activated clotting time method. Anaesthesia. 1980 Mar;35(3):250–256. doi: 10.1111/j.1365-2044.1980.tb05092.x. [DOI] [PubMed] [Google Scholar]
  17. Keeler J. F., Shah M. V., Hansbro S. D. Protamine--the need to determine the dose. Comparison of a simple protamine titration method with an empirical dose regimen for reversal of heparinisation following cardiopulmonary bypass. Anaesthesia. 1991 Nov;46(11):925–928. doi: 10.1111/j.1365-2044.1991.tb09848.x. [DOI] [PubMed] [Google Scholar]
  18. Lane D. A., Denton J., Flynn A. M., Thunberg L., Lindahl U. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J. 1984 Mar 15;218(3):725–732. doi: 10.1042/bj2180725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leyvraz P. F., Bachmann F., Hoek J., Büller H. R., Postel M., Samama M., Vandenbroek M. D. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ. 1991 Sep 7;303(6802):543–548. doi: 10.1136/bmj.303.6802.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leyvraz P. F., Richard J., Bachmann F., Van Melle G., Treyvaud J. M., Livio J. J., Candardjis G. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med. 1983 Oct 20;309(16):954–958. doi: 10.1056/NEJM198310203091605. [DOI] [PubMed] [Google Scholar]
  21. Lindahl U., Bäckström G., Hök M., Thunberg L., Fransson L. A., Linker A. Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3198–3202. doi: 10.1073/pnas.76.7.3198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Salzman E. W., Rosenberg R. D., Smith M. H., Lindon J. N., Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest. 1980 Jan;65(1):64–73. doi: 10.1172/JCI109661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Taberner D. A., Poller L., Thomson J. M., Lemon G., Weighill F. J. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery. Br J Surg. 1989 Sep;76(9):933–935. doi: 10.1002/bjs.1800760920. [DOI] [PubMed] [Google Scholar]
  24. Théroux P., Ouimet H., McCans J., Latour J. G., Joly P., Lévy G., Pelletier E., Juneau M., Stasiak J., deGuise P. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988 Oct 27;319(17):1105–1111. doi: 10.1056/NEJM198810273191701. [DOI] [PubMed] [Google Scholar]
  25. Turpie A. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Hull R. D., Gent M. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986 Oct 9;315(15):925–929. doi: 10.1056/NEJM198610093151503. [DOI] [PubMed] [Google Scholar]
  26. Turpie A. G., Robinson J. G., Doyle D. J., Mulji A. S., Mishkel G. J., Sealey B. J., Cairns J. A., Skingley L., Hirsh J., Gent M. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med. 1989 Feb 9;320(6):352–357. doi: 10.1056/NEJM198902093200604. [DOI] [PubMed] [Google Scholar]
  27. Van Ryn-McKenna J., Cai L., Ofosu F. A., Hirsh J., Buchanan M. R. Neutralization of enoxaparine-induced bleeding by protamine sulfate. Thromb Haemost. 1990 Apr 12;63(2):271–274. [PubMed] [Google Scholar]
  28. de Swiet M., Ward P. D., Fidler J., Horsman A., Katz D., Letsky E., Peacock M., Wise P. H. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynaecol. 1983 Dec;90(12):1129–1134. doi: 10.1111/j.1471-0528.1983.tb06459.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES